Leaflet HOLOXAN 2g powder for solution for infusion
Indicated for: cancer
Route of administration: infusion
Substance: ifosfamide (alkylating antineoplastic agent)
ATC: L01AA06 (Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Ifosfamide is a chemotherapy medication used to treat various types of cancer, including sarcomas, lymphomas, and testicular cancer. It belongs to the class of alkylating agents and works by interfering with the DNA of cancer cells, thereby inhibiting their growth and division.
The medication is administered via intravenous infusion under the supervision of an oncologist.
Side effects may include nausea, vomiting, hair loss, decreased blood cell counts, or hemorrhagic cystitis. In rare cases, severe allergic reactions or kidney dysfunction may occur.
Patients should be closely monitored during treatment and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should not use this medication.
General data about HOLOXAN 2g
- Substance: ifosfamide
- Date of latest medicines list: 01-07-2013
- Product code: W12496001
- Concentration: 2g
- Pharmaceutical form: powder for solution for infusion
- Quantity: 1
- Product type: Original
- Prescription status: S - Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.
Concentrations available for ifosfamide
- 1g
- 2g
- 500mg